BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Hsieh PS, Hsieh YJ. Impact of liver diseases on the development of type 2 diabetes mellitus. World J Gastroenterol 2011; 17(48): 5240-5245 [PMID: 22219592 DOI: 10.3748/wjg.v17.i48.5240]
URL: https://www.wjgnet.com/1007-9327/full/v17/i48/5240.htm
Number Citing Articles
1
Carmen Andrea Pfortmueller, Christoph Wiemann, Georg-Christian Funk, Alexander Benedikt Leichtle, Georg Martin Fiedler, Aristomenis Konstantinos Exadaktylos, Gregor Lindner. Hypoglycemia is associated with increased mortality in patients with acute decompensated liver cirrhosis. Journal of Critical Care 2014; 29(2) doi: 10.1016/j.jcrc.2013.11.002
2
Xuling Liu, Zuxin Liang, Hongwei Duan, Jianhai Yu, Zhiran Qin, Jingshu Li, Li Zhu, Qinghua Wu, Weiwei Xiao, Chenguang Shen, Chengsong Wan, Kefeng Wu, Hua Ye, Bao Zhang, Wei Zhao. Dengue virus is involved in insulin resistance via the downregulation of IRS-1 by inducing TNF-α secretion. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2022; 1868(10) doi: 10.1016/j.bbadis.2022.166472
3
Vladislav Volarevic, Maja Misirkic, Ljubica Vucicevic, Verica Paunovic, Bojana Simovic Markovic, Maja Stojanovic, Marija Milovanovic, Vladimir Jakovljevic, Dragan Micic, Nebojsa Arsenijevic, Vladimir Trajkovic, Miodrag L. Lukic. Metformin aggravates immune-mediated liver injury in mice. Archives of Toxicology 2015; 89(3) doi: 10.1007/s00204-014-1263-1
4
Yuanyuan Li, Ying Zhao, Jianping Wu, Ferruccio Bonino. Serum HBV surface antigen positivity is associated with low prevalence of metabolic syndrome: A meta-analysis. PLOS ONE 2017; 12(5) doi: 10.1371/journal.pone.0177713
5
Srishti Bhardwaj, Sonam Aggarwal, Naveen Kumar, Abhishek Prasad, Shrikant Mapari, Rajesh Kumar Kaushal. Transformer-enhanced deep ensemble for multi-class liver disease classification using computed tomography images. Scientific Reports 2026; 16(1) doi: 10.1038/s41598-026-43256-7
6
7
Yi-Wen Huang, Ting-Chuan Wang, Shih-Chang Lin, Han-Yu Chang, Ding-Shinn Chen, Jui-Ting Hu, Sien-Sing Yang, Jia-Horng Kao. Increased Risk of Cirrhosis and Its Decompensation in Chronic Hepatitis B Patients With Newly Diagnosed Diabetes: A Nationwide Cohort Study. Clinical Infectious Diseases 2013; 57(12) doi: 10.1093/cid/cit603
8
Chia‐Chi Wang, Tai‐Chung Tseng, Jia‐Horng Kao. Hepatitis B virus infection and metabolic syndrome: Fact or fiction?. Journal of Gastroenterology and Hepatology 2015; 30(1) doi: 10.1111/jgh.12700
9
Cong Zhang, Caiyun Sun, Bin Wang, Peipei Yan, Amin Wu, Guokun Yang, Wensheng Li. Orexin-A stimulates the expression of GLUT4 in a glucose dependent manner in the liver of orange-spotted grouper ( Epinephelus coioides ). Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology 2016; 199 doi: 10.1016/j.cbpa.2016.05.027
10
Taylor W. Cook, Amy M. Wilstermann, Jackson T. Mitchell, Nicholas E. Arnold, Surender Rajasekaran, Caleb P. Bupp, Jeremy W. Prokop. Understanding Insulin in the Age of Precision Medicine and Big Data: Under-Explored Nature of Genomics. Biomolecules 2023; 13(2) doi: 10.3390/biom13020257
11
L.-N. Xu, L.-H. Yin, Y. Jin, Y. Qi, X. Han, Y.-W. Xu, K.-X. Liu, Y.-Y. Zhao, J.-Y. Peng. Effect and possible mechanisms of dioscin on ameliorating metabolic glycolipid metabolic disorder in type-2-diabetes. Phytomedicine 2020; 67 doi: 10.1016/j.phymed.2019.153139
12
Ping-Hsin Hsieh, Jing-Yang Huang, Oswald Ndi Nfor, Chia-Chi Lung, Chien-Chang Ho, Yung-Po Liaw. Association of type 2 diabetes with liver cirrhosis: a nationwide cohort study. Oncotarget 2017; 8(46) doi: 10.18632/oncotarget.18466
13
André J. Scheen. Pharmacokinetics in Patients with Chronic Liver Disease and Hepatic Safety of Incretin-Based Therapies for the Management of Type 2 Diabetes Mellitus. Clinical Pharmacokinetics 2014; 53(9) doi: 10.1007/s40262-014-0157-y
14
Madiha R. Mahmoud, Somia Ibrahim, Mona M. Shahien, Amal Daher Alshammari, Fahaad S. Alenazi, Fayez Alreshidi, Ahmed Aljadani, Ashraf Abdel Khalik, Abeer H. Elhaj, Amany M. Khalifa, Hend Faleh Alreshidi, Hemat El-Sayed El-Horany, Kamaleldin B. Said, Marwa H. Abdallah, Amna A. Metwaly. Comparison Between the Impact of Diabetes Mellitus on Liver Diseases and Vice Versa Among Saudi and Egyptian Patients. Healthcare 2025; 13(4) doi: 10.3390/healthcare13040376
15
F. Rajas, P. Labrune, G. Mithieux. Glycogen storage disease type 1 and diabetes: Learning by comparing and contrasting the two disorders. Diabetes & Metabolism 2013; 39(5) doi: 10.1016/j.diabet.2013.03.002
16
Fei Lan, Hirofumi Misu, Keita Chikamoto, Hiroaki Takayama, Akihiro Kikuchi, Kensuke Mohri, Noboru Takata, Hiroto Hayashi, Naoto Matsuzawa-Nagata, Yumie Takeshita, Hiroyo Noda, Yukako Matsumoto, Tsuguhito Ota, Toru Nagano, Masatoshi Nakagen, Ken-ichi Miyamoto, Kanako Takatsuki, Toru Seo, Kaito Iwayama, Kunpei Tokuyama, Seiichi Matsugo, Hong Tang, Yoshiro Saito, Satoshi Yamagoe, Shuichi Kaneko, Toshinari Takamura. LECT2 Functions as a Hepatokine That Links Obesity to Skeletal Muscle Insulin Resistance. Diabetes 2014; 63(5) doi: 10.2337/db13-0728
17
Michael Leutner, Christian Göbl, Oliver Schlager, Silvia Charwat-Resl, Alice Wielandner, Eleonora Howorka, Marlies Prünner, Latife Bozkurt, Katharina Maruszczak, Hacer Geyik, Helmut Prosch, Giovanni Pacini, Alexandra Kautzky-Willer. The Fatty Liver Index (FLI) Relates to Diabetes-Specific Parameters and an Adverse Lipid Profile in a Cohort of Nondiabetic, Dyslipidemic Patients. Journal of the American College of Nutrition 2017; 36(4) doi: 10.1080/07315724.2016.1262802
18
John Marcinak, Majid Vakilynejad, Akifumi Kogame, Yoshihiko Tagawa. Evaluation of the Pharmacokinetics and Safety of a Single Oral Dose of Fasiglifam in Subjects with Mild or Moderate Hepatic Impairment. Drugs in R&D 2018; 18(2) doi: 10.1007/s40268-018-0229-9
19
Shintaro Yagi, Toshimi Kaido, Taku Iida, Atsushi Yoshizawa, Hideaki Okajima, Shinji Uemoto. New-onset diabetes mellitus after living-donor liver transplantation: association with graft synthetic function. Surgery Today 2017; 47(6) doi: 10.1007/s00595-016-1444-z
20
Ting Cai, Tingting Yue, Ming Xu, Pan Zhang, Yue Wang, Qi Liu, Jie Huang, Ting Shen, Qiang Yin, Zhifeng Sheng, Yang Xiao, Tuo Deng, Min Zhang, Erik De Clercq, Chi Zhang, Guangdi Li. Poor glycemic control in type‐2 diabetic patients infected with hepatitis B: A retrospective propensity‐matched study. Journal of Medical Virology 2023; 95(3) doi: 10.1002/jmv.28635
21
Pankaj Puri, Narendra Kotwal. An Approach to the Management of Diabetes Mellitus in Cirrhosis: A Primer for the Hepatologist. Journal of Clinical and Experimental Hepatology 2022; 12(2) doi: 10.1016/j.jceh.2021.09.010
22
Lindokuhle Patience Mabuza, Mlindeli Wilkinson Gamede, Sanam Maikoo, Irvin Noel Booysen, Phikelelani Siphosethu Nguban, Andile Khathi. Hepatoprotective Effects of a Ruthenium(II) Schiff Base Complex in Rats with Diet-Induced Prediabetes. Current Therapeutic Research 2019; 91 doi: 10.1016/j.curtheres.2019.100570
23
Javier Ampuero, Manuel Romero-Gómez. Influencia de la enfermedad por hígado graso no alcohólico en la enfermedad cardiovascular. Gastroenterología y Hepatología 2012; 35(8) doi: 10.1016/j.gastrohep.2012.02.005
24
Carlo B. Giorda, Elisa Nada, Barbara Tartaglino. Pharmacokinetics, safety, and efficacy of DPP-4 inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus and renal or hepatic impairment. A systematic review of the literature. Endocrine 2014; 46(3) doi: 10.1007/s12020-014-0179-0
25
André J Scheen. Pharmacokinetic and toxicological considerations for the treatment of diabetes in patients with liver disease. Expert Opinion on Drug Metabolism & Toxicology 2014; 10(6) doi: 10.1517/17425255.2014.902444
26
Hirofumi Misu. Pathophysiological significance of hepatokine overproduction in type 2 diabetes. Diabetology International 2018; 9(4) doi: 10.1007/s13340-018-0368-9
27
Yasmin Saad, Abobakr Awad, Wafaa Alakel, Wahid Doss, Tahany Awad, Mahasen Mabrouk. Data mining of routine laboratory tests can predict liver disease progression in Egyptian diabetic patients with hepatitis C virus (G4) infection: a cohort study of 71 806 patients. European Journal of Gastroenterology & Hepatology 2018; 30(2) doi: 10.1097/MEG.0000000000001008
28
Simona Alexandra Iacob, Diana Gabriela Iacob. Non-Alcoholic Fatty Liver Disease in HIV/HBV Patients – a Metabolic Imbalance Aggravated by Antiretroviral Therapy and Perpetuated by the Hepatokine/Adipokine Axis Breakdown. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.814209
29
Farah Abdelhameed, Lukasz Lagojda, Chris Kite, Alexander Dallaway, Attia Mustafa, Nwe Ni Than, Eva Kassi, Harpal S. Randeva, Ioannis Kyrou. Circulating angiopoietin-like protein 8 (ANGPTL8) and steatotic liver disease related to metabolic dysfunction: an updated systematic review and meta-analysis. Frontiers in Endocrinology 2025; 16 doi: 10.3389/fendo.2025.1574842
30
Chang-Hai Liu, Wei Jiang, Dong-Bo Wu, Qing-Min Zeng, You-Juan Wang, Hong Tang. Concomitant Diseases and Co-contribution on Progression of Liver Stiffness in Patients with Hepatitis B Virus Infection. Digestive Diseases and Sciences 2023; 68(4) doi: 10.1007/s10620-022-07695-2
31
Yi Shen, Sheng Zhang, Xulin Wang, Yuanyuan Wang, Jian Zhang, Gang Qin, Wenchao Li, Kun Ding, Lei Zhang, Feng Liang. Comparison of type 2 diabetes mellitus incidence in different phases of hepatitis B virus infection: A meta‐analysis. Liver International 2017; 37(10) doi: 10.1111/liv.13275
32
Yi-Wen Huang, Sien-Sing Yang, Szu-Chieh Fu, Ting-Chuan Wang, Cheng-Kai Hsu, Ding-Shinn Chen, Jui-Ting Hu, Jia-Horng Kao. Increased risk of cirrhosis and its decompensation in chronic hepatitis C patients with new-onset diabetes: A nationwide cohort study. Hepatology 2014; 60(3) doi: 10.1002/hep.27212
33
Thaïs Rouquet, Marion S Bonnet, Clément Pierre, Michel Dallaporta, Jean-Denis Troadec, Julien Roux, Bruno Bariohay. The Central Question of Type 2 Diabetes. Pharmaceutical Patent Analyst 2013; 2(3) doi: 10.4155/ppa.13.22
34
Wen-You Zhang, Huan-Huan Zhang, Chen-Huan Yu, Jie Fang, Hua-Zhong Ying. Ethanol extract of Atractylodis macrocephalae Rhizoma ameliorates insulin resistance and gut microbiota in type 2 diabetic db/db mice. Journal of Functional Foods 2017; 39 doi: 10.1016/j.jff.2017.10.020
35
C. H. Jung, W. J. Lee, J. Y. Hwang, J. H. Yu, M. S. Shin, M. J. Lee, J. E. Jang, J. Leem, J.‐Y. Park, H.‐K. Kim. Assessment of the fatty liver index as an indicator of hepatic steatosis for predicting incident diabetes independently of insulin resistance in a Korean population. Diabetic Medicine 2013; 30(4) doi: 10.1111/dme.12104
36
Fatma Elnaghy, Sameh Saber, Eman M. Abd El‐Kader, Mohammad A. Elmorsy, George S. G. Shehatou. Targeting TXNIP With Saroglitazar Mitigates Acute Hepatic Injury in Rats Challenged With Thioacetamide: A Multistep Computational and Experimental Approach. Archiv der Pharmazie 2025; 358(12) doi: 10.1002/ardp.70179
37
Marleen M.J. van Greevenbroek, Casper G. Schalkwijk, Coen D.A. Stehouwer. Inflammation - From Molecular and Cellular Mechanisms to the Clinic. 2017;  doi: 10.1002/9783527692156.ch47
38
Ye Zhang, Jiaojiao Huang, Sanshan Xia, Yan Yang, Kun Dong. Gender Difference in Liver Enzymes in Newly Defined Subgroups of Diabetes Revealed by a Data-Driven Cluster Analysis. Experimental and Clinical Endocrinology & Diabetes 2022; 130(11) doi: 10.1055/a-1799-8173
39
Xin Wang, Jing Ke, Ying-jun Zhu, Bin Cao, Rui-li Yin, Yan Wang, Ling-ling Wei, Li-jie Zhang, Long-yan Yang, Dong Zhao. Dipeptidyl peptidase-4 (DPP4) inhibitor sitagliptin alleviates liver inflammation of diabetic mice by acting as a ROS scavenger and inhibiting the NFκB pathway. Cell Death Discovery 2021; 7(1) doi: 10.1038/s41420-021-00625-7
40
Tao Xu, Yongheng Zhong, Shengyang Ji, Hang Xiao, Jun Li, Kaimian Li, Peiwu Li, Baiyi Lu. RS4 Type Resistant Starch Improves Type 2 Diabetes Mellitus in Mice by Interacting With Lactobacillus johnsonii. Food Frontiers 2025; 6(1) doi: 10.1002/fft2.528
41
Yange Wei, Haixia Yang, Chenhui Zhu, Jianjun Deng, Daidi Fan. Hypoglycemic Effect of Ginsenoside Rg5 Mediated Partly by Modulating Gut Microbiota Dysbiosis in Diabetic db/db Mice. Journal of Agricultural and Food Chemistry 2020; 68(18) doi: 10.1021/acs.jafc.0c00605
42
43
Alper Sonmez, Teoman Dogru, Cemal Nuri Ercin, Halil Genc, Gurkan Celebi, Hasan Gurel, Serkan Tapan, Ali Fuat Cicek, Cem Barcin, Cem Haymana, Ali Kirik, Manfredi Rizzo. Betatrophin Levels Are Related to the Early Histological Findings in Nonalcoholic Fatty Liver Disease. Metabolites 2021; 11(7) doi: 10.3390/metabo11070425
44
Xiu-Ping Bai, Yong-Mei Fan, Lei Zhang, Guo-Hua Yang, Xing Li. Influence of Liver Cirrhosis on Blood Glucose, Insulin Sensitivity and Islet Function in Mice. The American Journal of the Medical Sciences 2021; 362(4) doi: 10.1016/j.amjms.2021.07.005
45
Ahmed Tawheed, Abdulla A. Mahmoud, Hussein Hassan Aly, Mohamed El-Kassas. Coexistent Hepatitis B Virus and Metabolic Dysfunction-Associated Steatotic Liver Disease Under the New Definition: A New Era for Established Diseases. Livers 2026; 6(3) doi: 10.3390/livers6030044
46
Zobair Younossi, Katrin Kochems, Marc de Ridder, Desmond Curran, Eveline M. Bunge, Laurence de Moerlooze. Should adults with diabetes mellitus be vaccinated against hepatitis B virus? A systematic review of diabetes mellitus and the progression of hepatitis B disease. Human Vaccines & Immunotherapeutics 2017; 13(11) doi: 10.1080/21645515.2017.1353850
47
Filomena Carvalho, Alexandra Varges, Radhia Aitfella Lahlou, Eduardo Bárbara, Isa Santos, Cecília Fonseca, Luís R. Silva. Effects of Cherry Consumption on Metabolic Health: A Pilot Clinical Study on Healthy Adults. International Journal of Molecular Sciences 2025; 26(18) doi: 10.3390/ijms26188891
48
Yutang Wang, David Song, Tongzhi Wu, Eman M. Othman. Non-Fasting Glucose Measures and Their Clinical Significance in Diabetes Diagnosis and Cardiovascular and Cancer Risk Prediction: A Narrative Review. International Journal of Molecular Sciences 2026; 27(11) doi: 10.3390/ijms27114734
49
Roaid Khan, Graham R. Foster, Tahseen A. Chowdhury. Managing Diabetes in Patients with Chronic Liver Disease. Postgraduate Medicine 2012; 124(4) doi: 10.3810/pgm.2012.07.2574
50
Joo-Won Park, Woo-Jae Park, Yael Kuperman, Sigalit Boura-Halfon, Yael Pewzner-Jung, Anthony H. Futerman. Ablation of Very Long Acyl Chain Sphingolipids Causes Hepatic Insulin Resistance in Mice Due to Altered Detergent-Resistant Membranes. Hepatology 2013; 57(2) doi: 10.1002/hep.26015
51
Tae Woo Jung, Yoon Hee Chung, Hyoung-Chun Kim, A.M. Abd El-Aty, Ji Hoon Jeong. Hyperlipidemia-induced hepassocin in the liver contributes to insulin resistance in skeletal muscle. Molecular and Cellular Endocrinology 2018; 470 doi: 10.1016/j.mce.2017.10.014
52
Mina Bakhshaeshi, Arash Khaki, Fatemeh Fathiazad, Amir Afshin Khaki, Elham Ghadamkheir. Anti–oxidative role of quercetin derived from Allium cepa on aldehyde oxidase (OX–LDL) and hepatocytes apoptosis in streptozotocin–induced diabetic rat. Asian Pacific Journal of Tropical Biomedicine 2012; 2(7) doi: 10.1016/S2221-1691(12)60090-2
53
Muhammad Sadik Memon, Zain Islam Arain, Farukh Naz, Madiha Zaki, Suresh Kumar, Asif Ali Burney. Prevalence of Type 2 Diabetes Mellitus in Hepatitis C Virus Infected Population: A Southeast Asian Study. Journal of Diabetes Research 2013; 2013 doi: 10.1155/2013/539361
54
Jialin Zheng, Heng Li, Xiaojuan Zhang, Min Jiang, Chunqin Luo, Zhenming Lu, Zhenghong Xu, Jinsong Shi. Prebiotic Mannan-Oligosaccharides Augment the Hypoglycemic Effects of Metformin in Correlation with Modulating Gut Microbiota. Journal of Agricultural and Food Chemistry 2018; 66(23) doi: 10.1021/acs.jafc.8b00829